NEW YORK (Reuters Health) – A new clinical practice guideline from the American College of Physicians recommends strongly against the use of intensive insulin therapy to normalize high…
NEW YORK (Reuters Health) – A D-dimer level below 500 ng/mL reliably rules out acute aortic dissection, although the positive predictive value of a higher concentration is quite…
NEW YORK (Reuters Health) – In a randomized, single-center study of critically ill patients in an intensive care unit, permissive enteral underfeeding was associated with lower morbidity and…
NEW YORK (Reuters Health) – For patients who require stroke prevention therapy and who also undergo coronary stenting, combining oral anticoagulation with aspirin and clopidogrel provides better antithrombotic…
NEW YORK (Reuters Health) – Compared to the standard 75-mg/d maintenance dose of clopidogrel, 150 mg/d produces greater platelet inhibition, higher flow-mediated vasodilation, and reduced inflammation – all…
NEW YORK (Reuters Health) – For mild persistent asthma, fluticasone propionate with salmeterol cuts the risk of exacerbations more than ciclesonide, but both regimens effectively control daily symptoms.…
NEW YORK (Reuters Health) – In patients with stage 1 and 2 hypertension, the experimental angiotensin receptor blocker (ARB) azilsartan medoxomil lowers blood pressure better than maximal doses…
NEW YORK (Reuters Health) – An analysis of “real-life” data from a French myocardial infarction (MI) registry fails to show any clinically relevant interaction between clopidogrel and proton…
NEW YORK (Reuters Health) – Complete visualization of the entire small intestine is achieved more easily with double-balloon endoscopy than with single-balloon endoscopy, according to a report from…
NEW YORK (Reuters Health) – Suppressive therapy with corticosteroids and antihistamines is effective for managing clopidogrel hypersensitivity in the majority of cases, allowing antiplatelet therapy to continue uninterrupted,…